About - BioQL

Our Mission

BioQL was founded by SpectrixRD to democratize access to quantum computing for drug discovery. We believe that quantum algorithms can accelerate pharmaceutical research by orders of magnitude, making life-saving treatments available faster and more affordably.

What We Do

⚛️

Quantum Computing

Access to IBM Quantum, IonQ, Google, Azure, and AWS quantum processors

💊

Drug Discovery

Complete pipeline from docking to toxicity prediction

🧬

Gene Editing

CRISPR-QAI for optimized guide RNA design

Our Team

Founded in 2024, BioQL is developed by a team of quantum physicists, computational chemists, and software engineers at SpectrixRD. Our multidisciplinary approach combines cutting-edge quantum algorithms with deep pharmaceutical domain expertise.

Technology

✅ 164B+ natural language patterns for quantum programming
✅ 6 production-ready drug discovery modules
✅ Integration with 5 major quantum backends
✅ 21 CFR Part 11 compliance for pharmaceutical research
✅ Real-time cost optimization and error mitigation

Ready to get started?

Start Free Trial